Tag Archives: IP

IP in Latin America: Growing Recognition of the Importance of IP to Innovation

Photo by Márcio Cabral de Moura

The Inter-American Dialogue’s daily Latin America Advisor recently asked the question “How seriously do Latin American countries protect IP rights?”  The editors asked various stakeholders about the U.S. Trade Representative’s Special 301 Report and its evaluation of Latin America’s protection of IP rights.  BIO’s Director for International Affairs, Meredith Fensom, commented on the growth of the innovative biotechnology sectors in Latin America and the critical role intellectual property plays.  “The presence of more than 60 Read More >

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , , , ,

Session Summary: What Every CEO Must Know About IP In Biotech

Biotech Boot Camp

On Sunday, April 21st, 2013, I attended a standing room only session titled, “What Every CEO Must Know About IP In Biotech”, part of Day One of Entrepreneurship Boot Camp. Kathryn Doyle, Ph.D., J.D., of Riverside Law and Stephan Sammut of the Wharton School spoke about changing patent laws and what they mean for biotech companies. Concepts and tips discussed included: How to develop a patent strategy when developing a product you’re trying to commercialize When Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , ,

Kirtsaeng v. John Wiley & Sons: No Good Deed Goes Unpunished

Supreme Court

The Supreme Court handed Kirtsaeng a victory last week finding his importation and resale of copyrighted books exhausted the copyright under the First Sale Doctrine. In a vain attempt at corporate responsibility, the publishers in this case created two versions of textbooks; a no-frills “Asia edition” to sell at affordable prices to students in less affluent places like Thailand, and a higher quality more expensive version to relatively more affluent students in places like the Read More >

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , , ,

Spotlight on India’s Emerging Biotech Sector

india-flag

India’s biotechnology sector is a burgeoning one, with more than 325 companies and some with revenues in the billions of dollars. According to the BioSpectrum-ABLE (Association of Biotechnology Led Enterprises) Biotech Industry Survey of 2011, the industry has grown by 21.5% in 2006-2011, surging to $4 billion. Furthermore, India is the world’s largest manufacturer of vaccines and the growth of India vaccine makers arises from their ability to develop and produce high-quality vaccines with low Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , , ,

Prior User Rights and Trade Secrets

Research

By Joe Allen, President, Allen and Associates One theme of the day is the cloud of uncertainity overhanging the US patent system. This was underscored in the Prior User Rights and Trade Secrets session at the 2012 BIO International Convention as well. The new prior user rights defense which came into effect with enactment of the America Invents Act (AIA) was very differently viewed by the small biotech company perspective given by Mary Ann Dillahunty (Oncolytics Read More >

Patently BIOtech  |  1 Comment  |  Email This Post
Tags: , , , , , , ,